LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy

Author

Pascual García, Mónica

Bonfill Teixidor, Ester

Planas Rigol, Ester

Iurlaro, Raffaella

Arias Piñeiro, Alexandra

Cuartas Maza, Ma Isabel

Sala Hojman, Ada

Escudero Monreal, Laura

Martínez Ricarte, Francisco Ramón

Huber Ruano, Isabel

Nuciforo, Paolo Giovanni

Braña Garcia, Irene

Garralda Cabanas, Elena

Vieito Villar, Maria

Espejo Ruiz, Carmen

Sahuquillo Barris, Joan

Tabernero Caturla, Josep

Seoane Suarez, Joan

Rubio-Perez, Carlota

Other authors

Institut Català de la Salut

[Pascual-García M, Bonfill-Teixidor E] Vall d'Hebron Institut d'Oncologia, Barcelona, Spain. Hospital Universitari Vall d'Hebron, Barcelona, Spain. CIBERONC, Madrid, Spain. [Planas-Rigol E, Rubio-Perez C, Iurlaro R, Arias A, Cuartas I, Sala-Hojman A, Escudero L, Huber-Ruano I, Nuciforo P, Braña I, Garralda E, Vieito M] Vall d'Hebron Institut d'Oncologia, Barcelona, Spain. Hospital Universitari Vall d'Hebron, Barcelona, Spain. [Martínez-Ricarte F, Espejo C, Sahuquillo J] Vall d’Hebron Institut de Recerca, Barcelona, Spain. Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain. [Tabernero J] Vall d'Hebron Institut d'Oncologia, Barcelona, Spain. Hospital Universitari Vall d'Hebron, Barcelona, Spain. CIBERONC, Madrid, Spain. Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain. [Seoane J] Vall d'Hebron Institut d'Oncologia, Barcelona, Spain. Hospital Universitari Vall d'Hebron, Barcelona, Spain. CIBERONC, Madrid, Spain. Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

Vall d'Hebron Barcelona Hospital Campus

Publication date

2019-07-31T10:01:10Z

2019-07-31T10:01:10Z

2019-06-11

Abstract

Càncer; Macròfags associats al tumor: LIF; CD8


Cáncer; Macrófagos asociados al tumor; CD8


Cancer; Tumor-associated macrophages; CD8


Cancer response to immunotherapy depends on the infiltration of CD8+ T cells and the presence of tumor-associated macrophages within tumors. Still, little is known about the determinants of these factors. We show that LIF assumes a crucial role in the regulation of CD8+ T cell tumor infiltration, while promoting the presence of protumoral tumor-associated macrophages. We observe that the blockade of LIF in tumors expressing high levels of LIF decreases CD206, CD163 and CCL2 and induces CXCL9 expression in tumor-associated macrophages. The blockade of LIF releases the epigenetic silencing of CXCL9 triggering CD8+ T cell tumor infiltration. The combination of LIF neutralizing antibodies with the inhibition of the PD1 immune checkpoint promotes tumor regression, immunological memory and an increase in overall survival.

Document Type

Article
Published version

Language

English

Subjects and keywords

Medicaments antineoplàstics; Cèl·lules T - Immunologia; Citocines - Immunologia; Tumors - Tractament; DISEASES::Neoplasms; Other subheadings::Other subheadings::Other subheadings::/drug therapy; CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Cytokines::Leukemia Inhibitory Factor; ANATOMY::Cells::Blood Cells::Leukocytes::Leukocytes, Mononuclear::Lymphocytes::T-Lymphocytes::CD8-Positive T-Lymphocytes; Other subheadings::Other subheadings::Other subheadings::/immunology; ENFERMEDADES::neoplasias; Otros calificadores::Otros calificadores::Otros calificadores::/tratamiento farmacológico; COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::péptidos::péptidos y proteínas de señalización intercelular::citocinas::factor inhibidor de la leucemia; ANATOMÍA::células::células sanguíneas::leucocitos::leucocitos mononucleares::linfocitos::linfocitos T::linfocitos T CD8-positivos; Otros calificadores::Otros calificadores::Otros calificadores::/inmunología

Publisher

Nature Research

Related items

Nature Communications;10(1)

https://www.nature.com/articles/s41467-019-10369-9

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)